Peter Diamandis Launches NeoGenesis Capital, Betting on Superintelligence x Synthetic Biology
X Prize founder Peter Diamandis announced he is co-founding a new fund, NeoGenesis Capital, with Yianni Psaltis, focused on the intersection of "superintelligence × synthetic biology," arguing that the decade's biggest breakthroughs will emerge at this crossing point. He will share more details on the moonshots podcast.
Confirmed
- The fund is jointly launched by Diamandis and Yianni Psaltis, positioned as an investment fund focused on the intersection of programmable biology and AI
- Its strategy is concentrated investing in a single ecosystem: built around Colossal Biosciences, where Diamandis became an early investor five years ago
- Colossal founders Ben Lamm and George Church continue to advance work within the relevant ecosystem
Why it matters
- Diamandis founded X Prize and carries strong influence and rallying power; his personally setting up a themed fund signals a long-term bet on the programmable biology space
- The fund takes a concentrated ecosystem-investing approach rather than a diversified portfolio, deeply tied to Colossal's technology platform, so its success will hinge heavily on how this ecosystem develops
2026-10-14 ~ 2026-10-15 · 5 related posts
Primary sources
- [source] Peter Diamandis launches NeoGenesis Capital, a fund betting on superintelligence x synthetic biology — PeterDiamandis · 2026-10-14
- [source] Peter Diamandis Launches NeoGenesis Capital to Back Colossal's Programmable Biology Spinouts — PeterDiamandis · 2026-10-15
3 near-duplicate retellings: PeterDiamandis · PeterDiamandis · PeterDiamandis